Search

everythinglearnresearchcommunity

for

Search:↓

Many women with PCOS have abnormal cholesterol levels, needing careful management.

Some women with PCOS have rare genetic variants linked to the condition.

Early diagnosis and treatment of PCOS are crucial to reduce health risks and costs.

Significant progress was made in understanding androgen excess disorders, but much is still unknown.

Women with PCOS are more likely to develop kidney stones, especially those with certain PCOS types.

Early baldness in men may indicate risks for obesity, metabolic syndrome, insulin resistance, and heart disease, similar to women with PCOS. Alopecia areata is often linked with autoimmune diseases and mental health issues. Certain hair disorders are due to genetic issues, and chemotherapy can cause hair loss through specific biological pathways. Iron deficiency's link to hair loss is still disputed.

Continued research and awareness are needed to improve treatments for androgen-dependent diseases.

Alopecia and acne in women are complex conditions needing coordinated care and personalized treatment.

PCOS prevalence varies by ethnicity and location due to inconsistent diagnosis and limited research.

Different PCOS types respond uniquely to infertility treatments, with some having lower pregnancy rates and higher risks of complications.

Insulin resistance and high male hormone levels are major causes of Polycystic Ovary Syndrome.

Hispanic women with PCOS are more likely to have liver diseases like NAFLD and NASH.

Hormone imbalance is linked to Hidradenitis Suppurativa, a skin condition, and treatments like anti-androgenic therapy and metformin can help. It's also suggested to check patients for insulin resistance and Polycystic Ovary Syndrome.

Polycystic Ovary Syndrome (PCOS) in teenagers is a complex condition linked to genetics and environment, often associated with obesity and insulin resistance, and is treated with lifestyle changes and medication.

Sex hormones affect liver fat and metabolic health differently in men and women.

Dihydrotestosterone makes arteries stiffer in female mice by reducing estrogen receptor expression.

Women with Polycystic Ovary Syndrome (PCOS) have lower levels of a substance called DIAPH1 in their blood, which is linked to changes in sugar metabolism and insulin resistance.

Hormones affect prostate health and disease, with certain hormone imbalances linked to prostate cancer and benign prostatic hyperplasia.

The document concludes that a systematic approach is crucial to identify causes of androgen excess in women beyond the most common cause, Polycystic ovary syndrome (PCOS).

The document concludes that hair loss and acne in women can be due to both androgen-related and unrelated causes, requiring a collaborative treatment approach.

Non-classical 21 hydroxylase deficiency is an underdiagnosed cause of female hair loss and polycystic ovarian syndrome.

Women with PCOS are more likely to experience depressive symptoms.

Polycystic ovary syndrome causes chronic inflammation affecting all body systems, but proper nutrition, exercise, and supplements can improve the condition.

Effective PCOS treatments require targeting specific signaling pathways.

GLP-1 receptor agonists, like Dulaglutide, Liraglutide, and Semaglutide, have potential benefits beyond the pancreas, including neuroprotection, pain suppression, cardiovascular protection, obesity management, and cancer treatment, but there are concerns about pancreatitis and pancreatic cancer risks.

The document suggests various treatments for PCOS, including medication for menstrual issues, insulin resistance, and excess hair, as well as fertility treatments, while highlighting the need for personalized care and lifestyle changes.

The document says PCOS is a common hormonal disorder in women, diagnosed by certain criteria, and managed with lifestyle changes and various medications.

Oral contraceptives lower testosterone levels in women, especially those with certain genetic traits, and may be linked to increased breast cancer risk.

A new system helps better diagnose and treat female androgenization conditions like PCOS.

Genes and epigenetic changes are important in the development of Polycystic Ovary Syndrome.